Firocoxib Study Leads to Equine Canada Rule Change

Firocoxib is a non-steroidal anti-inflammatory drug used to treat musculoskeletal inflammation and pain in horses.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

By Jessica Semper

Results from a University of Saskatchewan Western College of Veterinary Medicine (WCVM) study have led to a nation-wide change in Equine Canada-sanctioned competition rules regulating the use of the drug firocoxib in performance horses.

The national equine sport organization’s rule change regarding firocoxib’s use came into effect on Jan. 1.

Firocoxib is a non-steroidal anti-inflammatory drug (NSAID) that’s used to treat musculoskeletal inflammation and pain in horses

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

What lameness issues has your horse experienced? Select all that apply.
268 votes · 536 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!